Cody Martin, M.D., an orthopedic surgeon specializing in primary and revision total hip and knee replacement, has joined Flagstaff-basedNorthern Arizona Orthopaedics (NAO), which is managed by Healthcare Outcomes Performance Company (HOPCo).
Cody Martin, M.D. Joins Northern Arizona Orthopaedics
1 min read Premium comments
#northernarizonaorthopaedics#codymartin
After earning his medical degree from the University of Utah, Dr. Martin received his residency training from the University of Florida College of Medicine. He then pursued fellowship training at the University of Virginia.
Dr. Martin’s NAO profile states, “Dr. Martin finds joy in alleviating patients’ pain by providing the best care he can. This dedicated surgeon has sought out advanced training by completing a fellowship to further specialize in joint replacement and adult reconstructive surgery of the hip and knee. Dr. Martin also treats general orthopaedic problems and traumatic injuries like broken bones or fractures.
“Dr. Cody Martin engages with his patients beyond just ascertaining pain and function levels, but truly strives to find out what is important to his patients and how he can most completely address their needs,says Carl DeRosa, Ph.D., CEO of Northern ArizonaOrthopaedics.
Dr. Martin told OTW, “My goal is to provide the very best care I can to the people of northern Arizona, and its visitors. I plan on doing my best to help my patients find relief from pain and disability and facilitate healing.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.